Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654K Buy
+60,200
New +$643K ﹤0.01% 4034
2025
Q4
Sell
-74,400
Closed -$995K 4901
2025
Q3
$995K Buy
74,400
+7,800
+12% +$92.2K ﹤0.01% 3463
2025
Q2
$852K Buy
66,600
+6,600
+11% +$79.2K ﹤0.01% 3338
2025
Q1
$618K Sell
60,000
-58,100
-49% -$748K ﹤0.01% 3372
2024
Q4
$1.5M Sell
118,100
-96,900
-45% -$1.28M ﹤0.01% 2939
2024
Q3
$2.75M Sell
215,000
-5,000
-2% -$61.2K ﹤0.01% 2446
2024
Q2
$2.79M Sell
220,000
-102,100
-32% -$1.77M ﹤0.01% 2327
2024
Q1
$7.3M Buy
+322,100
New +$7.54M 0.01% 1613
2022
Q3
Sell
-60,000
Closed -$1.09M 5438
2022
Q2
$1.09M Hold
60,000
﹤0.01% 3581
2022
Q1
$1.29M Buy
+60,000
New +$2.02M ﹤0.01% 3696

Other funds holding PATH

David Shaw's PATH Position: Q2 2026 in Review

David Shaw increased its UiPath (PATH) stake by 303% in Q2 2026, buying an estimated $37.9M and bringing the position to 4,719,704 shares worth $51.3M. The position accounts for 0.02% of the portfolio, ranked #746.

David Shaw first reported a position in PATH in Q2 2021 and has held it in 18 quarters since. The position peaked at $107M in Q2 2025. 525 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • David Shaw held 4,719,704 shares of UiPath worth $51.3M as of Q2 2026.
  • David Shaw bought 3,548,801 UiPath shares in Q2 2026, an estimated $37.9M.
  • UiPath made up 0.02% of David Shaw's portfolio in Q2 2026, its #746 holding.
  • David Shaw first reported a position in UiPath in Q2 2021 and has held it in 18 quarters since.
  • David Shaw's UiPath position peaked at $107M in Q2 2025.
  • 525 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.